A Cross-Sectional Study of Unmet Needs of Lymphoma Patients in Patient-Doctor Communication: Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL)

被引：0
|
作者：
Bamigbola, Olufunmilayo A. [1 ]
Dren, Natalie M. [1 ]
Warwick, Lorna E. [2 ]
机构：
[1] Lymphoma Coalit, Res, Mississauga, ON, Canada
[2] Lymphoma Coalit, Management, Mississauga, ON, Canada
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-123413
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4718
引用
收藏
页数：3
相关论文
共 50 条
  • [1] PATIENTS WITH FOLLICULAR LYMPHOMA (FL) SHOWING A DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) COMPONENT HAVE AN INTERMEDIATE OUTCOME BETWEEN FL AND DLBCL
    Magnano, L.
    Balague, O.
    Dlouhy, I.
    Rovira, J.
    Karube, K.
    Rivas, A.
    Gonzalez, B.
    Martinez-Trillos, A.
    Martinez, A.
    Delgado, J.
    Gine, E.
    Villamor, N.
    Campo, E.
    Lopez-Guillermo, A.
    HAEMATOLOGICA, 2016, 101 : 273 - 274
  • [2] PRAMS Expression in Follicular Lymphoma (FL) and Diffuse Large B Cell Lymphoma (DLBCL)
    Perez, M.
    Shafer, J. A.
    Curry, C.
    Zu, Y.
    Ewton, A.
    Dotti, G.
    Chang, C.
    MODERN PATHOLOGY, 2009, 22 : 280A - 281A
  • [3] PRAME Expression in Follicular Lymphoma (FL) and Diffuse Large B Cell Lymphoma (DLBCL)
    Perez, M.
    Shafer, J. A.
    Curry, C.
    Zu, Y.
    Ewton, A.
    Dotti, G.
    Chang, C.
    LABORATORY INVESTIGATION, 2009, 89 : 280A - 281A
  • [4] Statin Use and Prognosis in Patients with Follicular Lymphoma (FL) and Diffuse Large B Cell Lymphoma (DLBCL)
    Nowakowski, Grzegorz S.
    Maurer, Matthew J.
    Habermann, Thomas M.
    Ansell, Stephen M.
    Macon, William R.
    Ristow, Kay M.
    Allmer, Cristme
    Stager, Susan L.
    Witzig, Thomas E.
    Cerhan, James R.
    BLOOD, 2008, 112 (11) : 219 - 219
  • [5] Activity and safety of ibrutinib and durvalumab in patients with relapsed or refractory follicular lymphoma (FL) or diffuse large B-cell lymphoma (DLBCL)
    Herrera, A.
    Goy, A.
    Mehta, A.
    Ramchandren, R.
    Pagel, J.
    Svoboda, J.
    Guan, S.
    Hill, J.
    Kwei, K.
    Liu, E.
    Phillips, T.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E17 - E18
  • [6] Clinical Impact of the Presence of a Diffuse Large B-Cell Lymphoma (DLBCL) Component in the Outcome of Untreated Patients with Follicular Lymphoma (FL)
    Magnano, Laura
    Dlouhy, Ivan
    Balague, Olga
    Rivas-Delgado, Alfredo
    Rovira, Jordina
    Karube, Kennosuke
    Gonzalez, Blanca
    Martinez-Trillos, Alejandra
    Martinez, Antonio
    Delgado, Julio
    Gine, Eva
    Villamor, Neus
    Campo, Elias
    Lopez-Guillermo, Armando
    BLOOD, 2016, 128 (22)
  • [7] Rituximab Fails to Reduce Histologic Transformation (HT) Rate of Follicular Lymphoma (FL) to Diffuse Large B-Cell Lymphoma (DLBCL)
    Marciscano, Ariel E.
    Gupta, Neel
    Zhang, Zhigang
    Teruya-Feldstein, Julie
    Noy, Ariela
    BLOOD, 2008, 112 (11) : 310 - 310
  • [8] A Patient With Regressed Diffuse Large B-Cell Lymphoma and Aggressive Follicular Lymphoma
    Sethi, Ashish K.
    Haq, Bushra
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (05)
  • [9] Diffuse large B-cell lymphoma (DLBCL)
    Renner, C.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 82 : S10 - S10
  • [10] Understanding the patient experience in follicular lymphoma (FL), relapsed/refractory FL (R/R FL), and relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL)
    Bell, Jill A.
    Cherepanov, Dasha
    Revicki, Dennis
    Speck, Rebecca M.
    Swett, Laura
    Stumpo, Kate
    Rong, Yuanxin
    Gordon, Leo I.
    QUALITY OF LIFE RESEARCH, 2019, 28 : S67 - S68
12345